Structure

Physi-Chem Properties

Molecular Weight:  652.16
Volume:  593.063
LogP:  -0.24
LogD:  -0.318
LogS:  -3.002
# Rotatable Bonds:  10
TPSA:  264.5
# H-Bond Aceptor:  17
# H-Bond Donor:  8
# Rings:  5
# Heavy Atoms:  17

MedChem Properties

QED Drug-Likeness Score:  0.089
Synthetic Accessibility Score:  4.647
Fsp3:  0.448
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.585
MDCK Permeability:  5.242261249804869e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.988
Human Intestinal Absorption (HIA):  0.89
20% Bioavailability (F20%):  0.008
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.196
Plasma Protein Binding (PPB):  68.07852935791016%
Volume Distribution (VD):  0.616
Pgp-substrate:  14.620062828063965%

ADMET: Metabolism

CYP1A2-inhibitor:  0.08
CYP1A2-substrate:  0.053
CYP2C19-inhibitor:  0.023
CYP2C19-substrate:  0.062
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.138
CYP2D6-inhibitor:  0.079
CYP2D6-substrate:  0.173
CYP3A4-inhibitor:  0.015
CYP3A4-substrate:  0.011

ADMET: Excretion

Clearance (CL):  1.682
Half-life (T1/2):  0.789

ADMET: Toxicity

hERG Blockers:  0.727
Human Hepatotoxicity (H-HT):  0.093
Drug-inuced Liver Injury (DILI):  0.776
AMES Toxicity:  0.104
Rat Oral Acute Toxicity:  0.007
Maximum Recommended Daily Dose:  0.002
Skin Sensitization:  0.138
Carcinogencity:  0.197
Eye Corrosion:  0.003
Eye Irritation:  0.027
Respiratory Toxicity:  0.005

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC163165

Natural Product ID:  NPC163165
Common Name*:   6-[6-(4-O-Beta-D-Glucopyranosyloxy-3-Methoxybenzoyl)]-O-Beta-D-Glucopyranosyloxy-7-Hydroxycoumarin
IUPAC Name:   [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(7-hydroxy-2-oxochromen-6-yl)oxyoxan-2-yl]methyl 3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate
Synonyms:  
Standard InCHIKey:  GLBGTIVKNQKHLD-BTXJZROQSA-N
Standard InCHI:  InChI=1S/C29H32O17/c1-40-17-7-12(2-4-14(17)43-28-25(37)23(35)21(33)18(9-30)45-28)27(39)41-10-19-22(34)24(36)26(38)29(46-19)44-16-6-11-3-5-20(32)42-15(11)8-13(16)31/h2-8,18-19,21-26,28-31,33-38H,9-10H2,1H3/t18-,19-,21-,22-,23+,24+,25-,26-,28-,29-/m1/s1
SMILES:  OC[C@H]1O[C@@H](Oc2ccc(cc2OC)C(=O)OC[C@H]2O[C@@H](Oc3cc4ccc(=O)oc4cc3O)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL389851
PubChem CID:   16681193
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30984 Fraxinus sieboldiana Species Oleaceae Eukaryota stem bark n.a. n.a. PMID[17461599]
NPO30984 Fraxinus sieboldiana Species Oleaceae Eukaryota n.a. stem n.a. PMID[20961093]
NPO30984 Fraxinus sieboldiana Species Oleaceae Eukaryota Stem bark Lu Mountain, Jiangxi Province, China 2004-AUG PMID[20961093]
NPO30984 Fraxinus sieboldiana Species Oleaceae Eukaryota n.a. n.a. n.a. PMID[26697686]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT179 Cell Line A2780 Homo sapiens IC50 > 5000.0 nM PMID[520788]
NPT180 Cell Line HCT-8 Homo sapiens IC50 > 5000.0 nM PMID[520788]
NPT81 Cell Line A549 Homo sapiens IC50 > 5000.0 nM PMID[520788]
NPT2 Others Unspecified Inhibition = 30.8 % PMID[520788]
NPT1084 Subcellular Liver microsomes Rattus norvegicus IC50 > 10000.0 nM PMID[520788]
NPT27 Others Unspecified IC50 > 5000.0 nM PMID[520788]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC163165 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9695 High Similarity NPC84482
0.9695 High Similarity NPC169645
0.9573 High Similarity NPC5786
0.9573 High Similarity NPC102851
0.9451 High Similarity NPC197708
0.9451 High Similarity NPC658
0.9441 High Similarity NPC311803
0.9441 High Similarity NPC472859
0.9441 High Similarity NPC25389
0.9408 High Similarity NPC470446
0.9408 High Similarity NPC470449
0.9408 High Similarity NPC470447
0.9408 High Similarity NPC470445
0.9398 High Similarity NPC204693
0.9379 High Similarity NPC166277
0.9379 High Similarity NPC119125
0.9353 High Similarity NPC470455
0.9353 High Similarity NPC470451
0.9337 High Similarity NPC211594
0.9337 High Similarity NPC172807
0.9337 High Similarity NPC254540
0.9337 High Similarity NPC3583
0.9337 High Similarity NPC259152
0.9317 High Similarity NPC74319
0.9317 High Similarity NPC160780
0.9317 High Similarity NPC287872
0.9317 High Similarity NPC289811
0.929 High Similarity NPC470444
0.929 High Similarity NPC110941
0.929 High Similarity NPC473571
0.929 High Similarity NPC470443
0.929 High Similarity NPC473682
0.929 High Similarity NPC126784
0.929 High Similarity NPC241423
0.9286 High Similarity NPC472991
0.9286 High Similarity NPC169733
0.9286 High Similarity NPC472992
0.9268 High Similarity NPC142614
0.9264 High Similarity NPC90905
0.9264 High Similarity NPC33298
0.9264 High Similarity NPC285108
0.9264 High Similarity NPC4013
0.9259 High Similarity NPC203020
0.9259 High Similarity NPC239966
0.9255 High Similarity NPC1913
0.9231 High Similarity NPC472387
0.9231 High Similarity NPC476620
0.9231 High Similarity NPC173837
0.9231 High Similarity NPC476621
0.9231 High Similarity NPC120952
0.9231 High Similarity NPC476623
0.9231 High Similarity NPC476618
0.9231 High Similarity NPC476619
0.9231 High Similarity NPC476622
0.9226 High Similarity NPC102028
0.9226 High Similarity NPC477848
0.9226 High Similarity NPC142996
0.9222 High Similarity NPC307518
0.9222 High Similarity NPC472386
0.9222 High Similarity NPC475155
0.9222 High Similarity NPC205076
0.9222 High Similarity NPC48773
0.9217 High Similarity NPC86008
0.9217 High Similarity NPC93337
0.9217 High Similarity NPC475942
0.9217 High Similarity NPC201292
0.9217 High Similarity NPC198125
0.9217 High Similarity NPC95421
0.9217 High Similarity NPC209296
0.9217 High Similarity NPC105025
0.9217 High Similarity NPC469931
0.9217 High Similarity NPC58053
0.9217 High Similarity NPC45638
0.9217 High Similarity NPC195257
0.9217 High Similarity NPC186807
0.9217 High Similarity NPC226294
0.9181 High Similarity NPC473072
0.9181 High Similarity NPC36138
0.9172 High Similarity NPC8573
0.9172 High Similarity NPC211532
0.9172 High Similarity NPC89127
0.9172 High Similarity NPC472385
0.9172 High Similarity NPC198324
0.9172 High Similarity NPC470949
0.9172 High Similarity NPC297574
0.9172 High Similarity NPC233994
0.9172 High Similarity NPC471669
0.9172 High Similarity NPC65563
0.9167 High Similarity NPC239549
0.9167 High Similarity NPC219600
0.9167 High Similarity NPC51774
0.9167 High Similarity NPC473550
0.9167 High Similarity NPC472993
0.9167 High Similarity NPC46640
0.9167 High Similarity NPC263119
0.9167 High Similarity NPC236191
0.9167 High Similarity NPC166674
0.9167 High Similarity NPC34436
0.9162 High Similarity NPC105511
0.9162 High Similarity NPC21190
0.9162 High Similarity NPC224462
0.9162 High Similarity NPC34287
0.9162 High Similarity NPC22195
0.9162 High Similarity NPC183357
0.9162 High Similarity NPC51326
0.9162 High Similarity NPC231194
0.9162 High Similarity NPC44558
0.9162 High Similarity NPC471416
0.9162 High Similarity NPC474434
0.9157 High Similarity NPC45618
0.9157 High Similarity NPC58716
0.9157 High Similarity NPC116745
0.9157 High Similarity NPC146792
0.9146 High Similarity NPC148273
0.9141 High Similarity NPC289346
0.9136 High Similarity NPC472860
0.9128 High Similarity NPC21359
0.9128 High Similarity NPC470717
0.9128 High Similarity NPC25946
0.9128 High Similarity NPC470416
0.9128 High Similarity NPC470720
0.9128 High Similarity NPC148710
0.9128 High Similarity NPC470713
0.9128 High Similarity NPC460984
0.9123 High Similarity NPC473071
0.9123 High Similarity NPC473073
0.9118 High Similarity NPC475261
0.9112 High Similarity NPC294815
0.9112 High Similarity NPC473327
0.9112 High Similarity NPC43211
0.9112 High Similarity NPC210094
0.9112 High Similarity NPC49344
0.9112 High Similarity NPC101191
0.9112 High Similarity NPC237435
0.9112 High Similarity NPC253685
0.9112 High Similarity NPC198199
0.9112 High Similarity NPC16194
0.9112 High Similarity NPC19108
0.9112 High Similarity NPC264735
0.9112 High Similarity NPC115760
0.9112 High Similarity NPC220173
0.9112 High Similarity NPC476472
0.9112 High Similarity NPC135277
0.9107 High Similarity NPC301683
0.9107 High Similarity NPC156977
0.9107 High Similarity NPC180918
0.9107 High Similarity NPC476405
0.9107 High Similarity NPC267254
0.9107 High Similarity NPC117260
0.9102 High Similarity NPC95855
0.9102 High Similarity NPC472381
0.9102 High Similarity NPC183036
0.9102 High Similarity NPC472383
0.9102 High Similarity NPC210042
0.9102 High Similarity NPC229687
0.9102 High Similarity NPC149300
0.9102 High Similarity NPC112755
0.9102 High Similarity NPC471457
0.9102 High Similarity NPC170675
0.9096 High Similarity NPC99957
0.9096 High Similarity NPC181616
0.9096 High Similarity NPC115674
0.9096 High Similarity NPC8856
0.9096 High Similarity NPC210073
0.9091 High Similarity NPC121290
0.9085 High Similarity NPC217950
0.9075 High Similarity NPC473554
0.9075 High Similarity NPC470719
0.9075 High Similarity NPC295625
0.907 High Similarity NPC162394
0.907 High Similarity NPC470718
0.907 High Similarity NPC35924
0.907 High Similarity NPC199172
0.907 High Similarity NPC241781
0.907 High Similarity NPC156785
0.9068 High Similarity NPC327032
0.9068 High Similarity NPC194095
0.9068 High Similarity NPC191046
0.9064 High Similarity NPC471030
0.9064 High Similarity NPC473895
0.9059 High Similarity NPC472382
0.9059 High Similarity NPC67629
0.9059 High Similarity NPC472384
0.9059 High Similarity NPC79736
0.9059 High Similarity NPC472380
0.9059 High Similarity NPC473862
0.9059 High Similarity NPC268533
0.9059 High Similarity NPC257714
0.9053 High Similarity NPC208668
0.9053 High Similarity NPC175230
0.9053 High Similarity NPC4390
0.9053 High Similarity NPC172033
0.9053 High Similarity NPC21666
0.9053 High Similarity NPC42773
0.9053 High Similarity NPC169977
0.9053 High Similarity NPC101026
0.9053 High Similarity NPC88560
0.9053 High Similarity NPC24043
0.9053 High Similarity NPC45522
0.9048 High Similarity NPC204937

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC163165 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9277 High Similarity NPD7472 Approved
0.9217 High Similarity NPD7054 Approved
0.9112 High Similarity NPD4338 Clinical (unspecified phase)
0.9053 High Similarity NPD7251 Discontinued
0.9048 High Similarity NPD7074 Phase 3
0.9 High Similarity NPD7808 Phase 3
0.8994 High Similarity NPD6797 Phase 2
0.8817 High Similarity NPD3818 Discontinued
0.8758 High Similarity NPD1653 Approved
0.8727 High Similarity NPD4868 Clinical (unspecified phase)
0.8563 High Similarity NPD4381 Clinical (unspecified phase)
0.8555 High Similarity NPD7993 Clinical (unspecified phase)
0.8494 Intermediate Similarity NPD2801 Approved
0.848 Intermediate Similarity NPD6166 Phase 2
0.848 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.848 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8439 Intermediate Similarity NPD5844 Phase 1
0.8439 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.84 Intermediate Similarity NPD7685 Pre-registration
0.8383 Intermediate Similarity NPD1465 Phase 2
0.8323 Intermediate Similarity NPD1934 Approved
0.8276 Intermediate Similarity NPD7228 Approved
0.8225 Intermediate Similarity NPD3817 Phase 2
0.8166 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8118 Intermediate Similarity NPD5402 Approved
0.807 Intermediate Similarity NPD3882 Suspended
0.8035 Intermediate Similarity NPD5494 Approved
0.8025 Intermediate Similarity NPD7266 Discontinued
0.8023 Intermediate Similarity NPD7075 Discontinued
0.7989 Intermediate Similarity NPD6559 Discontinued
0.7989 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD4380 Phase 2
0.7978 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD1511 Approved
0.7917 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7912 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD8313 Approved
0.7901 Intermediate Similarity NPD8312 Approved
0.7889 Intermediate Similarity NPD7240 Approved
0.7886 Intermediate Similarity NPD7199 Phase 2
0.7874 Intermediate Similarity NPD6234 Discontinued
0.7857 Intermediate Similarity NPD1512 Approved
0.7849 Intermediate Similarity NPD8455 Phase 2
0.7849 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7831 Intermediate Similarity NPD6190 Approved
0.7826 Intermediate Similarity NPD230 Phase 1
0.7791 Intermediate Similarity NPD37 Approved
0.7791 Intermediate Similarity NPD6801 Discontinued
0.7759 Intermediate Similarity NPD4965 Approved
0.7759 Intermediate Similarity NPD4967 Phase 2
0.7759 Intermediate Similarity NPD4966 Approved
0.7746 Intermediate Similarity NPD7819 Suspended
0.774 Intermediate Similarity NPD6232 Discontinued
0.7709 Intermediate Similarity NPD7473 Discontinued
0.7706 Intermediate Similarity NPD5403 Approved
0.7697 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD3751 Discontinued
0.7665 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD7783 Phase 2
0.7653 Intermediate Similarity NPD8151 Discontinued
0.7633 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD6799 Approved
0.763 Intermediate Similarity NPD7411 Suspended
0.7588 Intermediate Similarity NPD5401 Approved
0.7577 Intermediate Similarity NPD7435 Discontinued
0.756 Intermediate Similarity NPD3750 Approved
0.756 Intermediate Similarity NPD4628 Phase 3
0.7546 Intermediate Similarity NPD1613 Approved
0.7546 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD1549 Phase 2
0.7542 Intermediate Similarity NPD3787 Discontinued
0.7531 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD7585 Approved
0.75 Intermediate Similarity NPD1933 Approved
0.75 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD447 Suspended
0.7486 Intermediate Similarity NPD6959 Discontinued
0.7485 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7462 Intermediate Similarity NPD7583 Approved
0.7461 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD2796 Approved
0.7423 Intermediate Similarity NPD6781 Approved
0.7423 Intermediate Similarity NPD6777 Approved
0.7423 Intermediate Similarity NPD6776 Approved
0.7423 Intermediate Similarity NPD6780 Approved
0.7423 Intermediate Similarity NPD6778 Approved
0.7423 Intermediate Similarity NPD6779 Approved
0.7423 Intermediate Similarity NPD6782 Approved
0.7401 Intermediate Similarity NPD5353 Approved
0.7398 Intermediate Similarity NPD7698 Approved
0.7398 Intermediate Similarity NPD7680 Approved
0.7398 Intermediate Similarity NPD7696 Phase 3
0.7398 Intermediate Similarity NPD7697 Approved
0.7384 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7374 Intermediate Similarity NPD919 Approved
0.7371 Intermediate Similarity NPD6599 Discontinued
0.7365 Intermediate Similarity NPD1510 Phase 2
0.7362 Intermediate Similarity NPD3027 Phase 3
0.736 Intermediate Similarity NPD7768 Phase 2
0.735 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.735 Intermediate Similarity NPD7874 Approved
0.7337 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7337 Intermediate Similarity NPD7701 Phase 2
0.7321 Intermediate Similarity NPD1551 Phase 2
0.7321 Intermediate Similarity NPD2935 Discontinued
0.7318 Intermediate Similarity NPD3749 Approved
0.7314 Intermediate Similarity NPD7458 Discontinued
0.7301 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7293 Intermediate Similarity NPD1247 Approved
0.7286 Intermediate Similarity NPD7584 Approved
0.7273 Intermediate Similarity NPD7549 Discontinued
0.7273 Intermediate Similarity NPD7871 Phase 2
0.7273 Intermediate Similarity NPD7870 Phase 2
0.7262 Intermediate Similarity NPD3748 Approved
0.7259 Intermediate Similarity NPD6823 Phase 2
0.7239 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7239 Intermediate Similarity NPD9494 Approved
0.7231 Intermediate Similarity NPD7700 Phase 2
0.7231 Intermediate Similarity NPD7699 Phase 2
0.7211 Intermediate Similarity NPD8434 Phase 2
0.7198 Intermediate Similarity NPD8127 Discontinued
0.7193 Intermediate Similarity NPD1652 Phase 2
0.7184 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7165 Intermediate Similarity NPD6534 Approved
0.7165 Intermediate Similarity NPD6535 Approved
0.7151 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7801 Approved
0.7143 Intermediate Similarity NPD9269 Phase 2
0.7135 Intermediate Similarity NPD6386 Approved
0.7135 Intermediate Similarity NPD6385 Approved
0.7126 Intermediate Similarity NPD943 Approved
0.7126 Intermediate Similarity NPD1240 Approved
0.712 Intermediate Similarity NPD3926 Phase 2
0.712 Intermediate Similarity NPD8150 Discontinued
0.712 Intermediate Similarity NPD5242 Approved
0.7102 Intermediate Similarity NPD920 Approved
0.71 Intermediate Similarity NPD8320 Phase 1
0.71 Intermediate Similarity NPD8319 Approved
0.7093 Intermediate Similarity NPD6674 Discontinued
0.7092 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6832 Phase 2
0.7086 Intermediate Similarity NPD2532 Approved
0.7086 Intermediate Similarity NPD2534 Approved
0.7086 Intermediate Similarity NPD2533 Approved
0.7083 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD5124 Phase 1
0.7081 Intermediate Similarity NPD1091 Approved
0.7066 Intermediate Similarity NPD6233 Phase 2
0.7055 Intermediate Similarity NPD3225 Approved
0.7041 Intermediate Similarity NPD1607 Approved
0.7039 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7037 Intermediate Similarity NPD7038 Approved
0.7037 Intermediate Similarity NPD7039 Approved
0.7022 Intermediate Similarity NPD3226 Approved
0.7022 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD1203 Approved
0.7 Intermediate Similarity NPD6844 Discontinued
0.7 Intermediate Similarity NPD7097 Phase 1
0.7 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6989 Remote Similarity NPD642 Clinical (unspecified phase)
0.6985 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6984 Remote Similarity NPD5953 Discontinued
0.6982 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6975 Remote Similarity NPD422 Phase 1
0.6968 Remote Similarity NPD7286 Phase 2
0.6959 Remote Similarity NPD4308 Phase 3
0.6959 Remote Similarity NPD7033 Discontinued
0.6939 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6939 Remote Similarity NPD6213 Phase 3
0.6939 Remote Similarity NPD6212 Phase 3
0.6934 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6100 Approved
0.6919 Remote Similarity NPD6099 Approved
0.6909 Remote Similarity NPD2797 Approved
0.6905 Remote Similarity NPD6798 Discontinued
0.6905 Remote Similarity NPD3268 Approved
0.6897 Remote Similarity NPD1243 Approved
0.6894 Remote Similarity NPD9268 Approved
0.6886 Remote Similarity NPD4908 Phase 1
0.6882 Remote Similarity NPD7229 Phase 3
0.6882 Remote Similarity NPD6355 Discontinued
0.6875 Remote Similarity NPD643 Clinical (unspecified phase)
0.6854 Remote Similarity NPD6273 Approved
0.6832 Remote Similarity NPD9545 Approved
0.6831 Remote Similarity NPD4288 Approved
0.6829 Remote Similarity NPD9717 Approved
0.6821 Remote Similarity NPD6842 Approved
0.6821 Remote Similarity NPD6841 Approved
0.6821 Remote Similarity NPD6843 Phase 3
0.6809 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6805 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6805 Remote Similarity NPD2313 Discontinued
0.6782 Remote Similarity NPD2346 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data